According to SPER Market Research, the Epilepsy Monitoring Devices Market is 0.5% of diseases that are prevalent worldwide. Years of treatment are needed for epilepsy, which has financial consequences and a risk of patient mortality. The majority of epilepsy sufferers come from low- or middle-income nations. Additionally, the inadequate healthcare infrastructure prevents patients from receiving the essential care and causes them to pass away too soon.
The wearable form of epilepsy monitoring equipment makes them more convenient to use and effective for continuous monitoring. During the projected period, the market is expected to increase as a result of factors including rising demand for continuous monitoring, rising awareness of neurological illnesses, and rising wearable device usage.
Market Overview (2022-2030)
• Forecast CAGR (2022-2030): 4.5%
• Forecast Market Size (2030): 724 Million
An epileptic patient’s seizures are regularly monitored with epilepsy monitoring equipment. When a seizure occurs in a patient who is associated to it, the device essentially alerts the caregivers or healthcare professionals. According to market share, the market for traditional devices has the largest product segment. Increased desire for less invasive procedures, increased awareness of neurological illnesses, and rising demand for ongoing brain monitoring are primarily responsible for the high proportion of this market. Due to the expanding prevalence of neurological illnesses, government initiatives, improved reimbursement practises, and increased financing for R&D in the healthcare sector, North America dominated the market when it came to regional segmentation.
Global Epilepsy Monitoring Devices Market Insights, Size and Growth Forecast To 2030
Impact of COVID-19 on the Epilepsy Monitoring Devices Market
During the COVID-19 pandemic, many hospitals suspended the neurology procedures temporarily. The procurement of products was also difficult for indications other than COVID-19 due to disruption of supply chain. The fluctuations in the logistics supply cost will continue to last until COVID-19 cases continue to rise. The rising demand for wearable monitoring devices is expected to grow this market for wearable segment considering the social distancing norms.
Industry Definition and Major Segments:
The SPER Market Research report seeks to give market dynamics, demand, and supply forecasts for the years up to 2030. This report contains statistics on product type segment growth estimates and forecasts.
Epilepsy Monitoring Devices Market by Product:
• Conventional Devices
• Wearable Devices
Epilepsy Monitoring Devices Market by End User:
• Hospitals and Clinics
• Home Care Settings
• Others
Epilepsy Monitoring Devices Market by Region:
• North America
• Europe
• Asia-Pacific
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Key Market Players:
The global epilepsy monitoring devices market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as Abbott Laboratories, Inc., Advanced Brain Monitoring, Aleva Neurotherapeutics, BioSerenity, Boston Scientific Corporation, Cadwell Industries, Inc., CGX, Compumedics Limited, Drägerwerk AG & Co. KGaA, Emotiv, Empatica, Inc., Lifelines Neuro Company, LLC, LivAssured B.V., Masimo Corporation, MC10, Inc., Medpage, Ltd., Medtronic Plc, Mindray Medical International Ltd., Mitsar Co., Ltd., mjn Neuroserveis S.L., Natus Medical, Inc., Neurosoft, NeuroWave Systems, Inc., Nihon Kohden Corporation, Rimed, The Magstim Co. Ltd.
About Company:
SPER Market Research® is one of the world’s most trusted market research, market intelligence, and consulting companies offering strategic research, custom research, market intelligence solutions, quantitative data collection, qualitative fieldwork, online research panel, and consumer research. Headquartered in India, the company has offices worldwide and provides strategic & consulting services.
SPER Market Research study aims to provide market dynamics, demand, and supply with a yearly forecast for 2030. We have served over 20 industries, with core offerings in Pharmaceutical/Healthcare, Business to Business research (B2B), Nutraceuticals, Food & Beverages, cosmetics, Dermatology, Dental, Herbal, Chemical, Consumer, Information Technology, and other industries.
Contact Us:
Company Name: SPER Market Research
Contact Person: Lucia Jones, Business Consultant – U.S.A.
Email: info@sperresearch.com
Contact Number: 1-347-460-2899
Address: 6 Sunflower Court, Holtsville, NY 11742, USA
Website: https://www.sperresearch.com
We at SPER Market Research always thrive to give you the most recent data. The numbers in the article are just characteristic and may be different from the genuine report.
